Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
Patient Safety Program Medication Safety Notice 1 - Varenicline

Patient Safety Program Medication Safety Notice 1 - Varenicline

Ratings: (0)|Views: 38|Likes:
Published by d40sithui
Patient Safety Program Medication Safety Notice 1 - Varenicline
Patient Safety Program Medication Safety Notice 1 - Varenicline

More info:

Published by: d40sithui on Jun 17, 2009
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less





Issue 1 - 23 May 2008
Varenicline (Chantix)
On 21 May 2008, the Institute for Safe Medication Practice (ISMP) released a report onstrong adverse safety signals associated with Chantix (varenicline). Varenicline isincreasingly used across the country and within DoD in smoking cessation programs.Quoting from the recommendations in ISMP's report Executive Summary:We have immediate safety concerns about the use of varenicline amongpersons operating aircraft, trains, buses and other vehicles, or in other settingswhere a lapse in alertness or motor control could lead to massive, serious injury.Other examples include persons operating nuclear power reactors, high-riseconstruction cranes or life-sustaining medical devices. Based on reports of suddenloss of consciousness, seizures, muscle spasms, vision disturbances,hallucinations, paranoia and psychosis, we believe varenicline may not be safe touse in these settings. The extent to which varenicline has already contributed toaccidental death and injury has not yet been investigated because these adverseeffects had not been previously reported. The Federal Aviation Administrationapproved varenicline for use by airline pilots
before most of these reports wereavailable. [On the day this report was released the FAA withdrew that approval.]In addition, we recommend that patients and doctors exercise caution inthe use of varenicline and consider the use of alternative approaches to smokingcessation.Studies of varenicline prescriptions in military treatment facilities show increasingutilization from 262 prescriptions in FY 2006, when varenicline was first licensed foruse, to 67,580 prescriptions in FY 2007. At the same time, Zyban (bupropion - anothersmoking cessation drug and not implicated in the ISMP study) use decreased from 37,261to 23,975 prescriptions.The safety and health of our men and women in uniform is paramount. Assisting withtheir desires to stop smoking is important wherever they are assigned and whatever theirmission is. However, ensuring that they are given and use medications that do not putthem and others at increased risk of injury or death is essential.

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->